ML-095 hydrochloride
CAS No. 1135318-57-8
ML-095 hydrochloride( MLS-0315848 hydrochloride | CID-25067483 hydrochloride )
Catalog No. M23323 CAS No. 1135318-57-8
ML095 hydrochloride is a specific placental alkaline phosphatase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 55 | In Stock |
|
| 2MG | 30 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 84 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 291 | In Stock |
|
| 100MG | 423 | In Stock |
|
| 200MG | 594 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameML-095 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionML095 hydrochloride is a specific placental alkaline phosphatase inhibitor.
-
DescriptionML095 hydrochloride is a specific placental alkaline phosphatase inhibitor. It inhibits PLAP, TNAP and IAP with IC50 of 2.1, >100 and 53 μM, respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsMLS-0315848 hydrochloride | CID-25067483 hydrochloride
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
RecptorPLAP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1135318-57-8
-
Formula Weight282.72
-
Molecular FormulaC13H15ClN2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCC1=NC=CN1CC(=O)C2=CC(=C(C=C2)O)O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sergienko E , Garcia X , Brown B , et al. Placental Alkaline Phosphatase (PLAP) Luminescent HTS assay - Probe 2[M]// Probe Reports from the NIH Molecular Libraries Program. PubMed, 2010.
molnova catalog
related products
-
Darapladib
A potent Lp-PLA2 inhibitor with IC50 of 0.25 nM.
-
U 73343
U 73343 is an inactive analog of U 73122 and can be used as a negative control. It dose-dependently inhibits acid secretion irrespective of the stimulant.
-
Bromoenol lactone
Bromoenol lactone ((6E)-Bromoenol lactone) is a selective calcium-dependent phospholipase A2?(iPLA2β) and serine protease inhibitor that attenuates nicotine-induced breast cancer cell proliferation and migrations.
Cart
sales@molnova.com